NCT05198843 2025-10-03
Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body
National Cancer Institute (NCI)
Phase 1/2 Terminated
Clinical Trials
6 trialsNCT03428477 2025-04-18
EMT2
University of Leeds
Phase 3 Active not recruiting
NCT04216251 2024-05-03
PREPARE
Massachusetts General Hospital
Phase 1/2 Completed
NCT03661047 2021-11-17
OMICC
Massachusetts General Hospital
Phase 2 Withdrawn
NCT02940223 2021-06-10
Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00146211 2007-12-27
TREND-HD - A Trial of Ethyl-EPA (Miraxionâ„¢) in Treating Mild to Moderate Huntington's Disease
Amarin Neuroscience Ltd
Phase 3 Completed